Veterinary Compounding - A Customized Approach
One of the biggest challenges in pharmaceutical therapy for veterinary care is the fact that most medications are manufactured with an intended use in humans, not animals. While the active pharmaceutical ingredients in these products may be effective in treating animal diseases and conditions, different formulations of the drug are often required in order to meet species-unique physiological and behavioral needs. Common considerations when compounding veterinary pharmaceuticals include dosage form (e.g., chewable treats or transdermal therapy in place of oral tablets), dose, and palatability. The unique niche of veterinary compounding allows for the veterinarian and/or pharmacist to develop medications tailored to the individual needs of the animal that are otherwise not commercially available.
- Pharmacy Managers
- Identify challenges and obstacles in veterinary medicine that can be overcome with pharmaceutical compounding.
- Identify examples of drugs that are contraindicated or are likely to cause toxicity in animals.
- Discuss and compare the benefits of various dosage forms used in veterinary compounding, including chewable treats, topical or transdermal preparations, shampoos, inhalants, oral pastes, and suppositories.
- Understand the flavoring options available for species-specific taste preferences in order to improve palatability of oral medication.
- Describe compounding solutions for animal patient non-compliance.
High speed internet connectivity and an updated internet browser is required to attend the webinar. The broadband recommended is 1 Mbps or better. The minimum browser requirements to attend the webinar are:
- Google Chrome v39 or later
- Mozilla Firefox v34 or later
- Internet Explorer v8 or later
- Microsoft Edge
- Apple Safari v6 or later
SHANNON BELLEVUE, MSc
LP3 Network Facilitator
Shannon Bellevue completed her Bachelor degree in Behavioral Neuroscience at Concordia University, where she studied the effects of hormone replacement therapy in animal models and the mechanisms of drug addiction and pharmacology. Following this, Ms. Bellevue decided to pursue a Master’s degree in Neuroscience at Carleton University, where she specialized her research in the neural mechanisms and pharmaceutical treatment of neurodegenerative diseases. During this time, she acquired specialized knowledge in human and animal pharmacokinetics and gained valuable skills in laboratory research, scientific writing, and teaching. Throughout the course of her academic career, Ms. Bellevue became passionate about the necessity for personalized healthcare. In pursuit of this passion, she has since acquired a position at LP3 Network, where she provides expert knowledge in the application of compounded pharmaceuticals for specific populations, most notably, veterinary care.
VANESSA PINHEIRO, BS Pharm, MSc, RPh
Pharmacist, Technical Support Services Department, MEDISCA Network
Mrs. Pinheiro is a compounding pharmacist with over 19 years of experience, and was previously a professor at the College of Pharmacy at the University Suprema in Brazil. She was previously the owner of RX Pharmaceutica and Petfarma Pharmacies in Brazil, for which she was responsible for compounding, quality control of raw-materials and final products, training pharmacists and technicians, and counseling patients. Mrs. Pinheiro was a Surveyor and Standards Committee member of Brazil’s National Association of Pharmaceutical Masters, a non-profit organization that oversees customized pharmaceutical preparations. She has specialty training in non-sterile compounding, pharmaceutical technology, cosmetology, and veterinary compounding. She is also the author of the veterinary formulary book, Formulário Veterinário Farmacêutico.